Research database

SVF Research Library

Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 10 matching records.

Search the database

Evidence

Sort

10 results — page 1 of 1

Level BClinical TrialEurope PMC
Nebulization of Mesenchymal Stem Cells Secretome Attenuates Acute Respiratory Distress Syndrome Caused by SARS-CoV-2 Corona Virus: An Open-Label, Controlled Trial
Clinical Trial with a reported sample of 19 on Chronic Inflammation, Immune Modulation, published in Adv Biomed Res (2025) — summary generated from the PubMed abstract.
2025
Adv Biomed Res
n = 19
Level DAnimal StudyPubMed
Therapeutic potential of mesenchymal stem cell-derived extracellular vesicles in SARS-CoV-2 and H1N1 influenza-induced acute lung injury.
Animal Study on Chronic Inflammation, published in J Extracell Vesicles (2024) — summary generated from the PubMed abstract.
2024
J Extracell Vesicles
Level DLaboratory StudyPubMed
Human mesenchymal stromal cells do not express ACE2 and TMPRSS2 and are not permissive to SARS-CoV-2 infection.
Laboratory Study on Chronic Inflammation, Immune Modulation, published in Stem Cells Transl Med (2021) — summary generated from the PubMed abstract.
2021
Stem Cells Transl Med
Level BClinical TrialEurope PMC
Mesenchymal stromal cells to fight SARS-CoV-2: Taking advantage of a pleiotropic therapy
Clinical Trial with a reported sample of 19 on Immune Modulation, published in Cytokine Growth Factor Rev (2021) — summary generated from the PubMed abstract.
2021
Cytokine Growth Factor Rev
18 citations
n = 19
Level BClinical TrialEurope PMC
Mesenchymal Stem Cell-Derived Exosomes Exhibit Promising Potential for Treating SARS-CoV-2-Infected Patients
Clinical Trial with a reported sample of 19 on Chronic Inflammation, Immune Modulation, published in Cells (2021) — summary generated from the PubMed abstract.
2021
Cells
38 citations
n = 19
Level DLaboratory StudyPubMed
SARS-CoV-2: the "Uncensored" Truth about Its Origin and Adipose-Derived Mesenchymal Stem Cells as New Potential Immune-Modulatory Weapon.
Laboratory Study, published in Aging Dis (2021) — summary generated from the PubMed abstract.
2021
Aging Dis
21 citations
Level DNarrative ReviewEurope PMC
Mesenchymal stem cells in SARS-CoV-2 infection: A hype or hope
Narrative Review on Chronic Inflammation, Immune Modulation, published in Life Sci (2021) — summary generated from the PubMed abstract.
2021
Life Sci
2 citations
Level CProspective StudyPubMed
Adipose-derived mesenchymal stromal cells for the treatment of patients with severe SARS-CoV-2 pneumonia requiring mechanical ventilation. A proof of concept study.
Prospective Study on Chronic Inflammation, published in EClinicalMedicine (2020) — summary generated from the PubMed abstract.
2020
EClinicalMedicine
138 citations
Level BClinical TrialPubMed
Human Mesenchymal Stromal Cells Are Resistant to SARS-CoV-2 Infection under Steady-State, Inflammatory Conditions and in the Presence of SARS-CoV-2-Infected Cells.
Clinical Trial with a reported sample of 19 on Immune Modulation, published in Stem Cell Reports (2020) — summary generated from the PubMed abstract.
2020
Stem Cell Reports
33 citations
n = 19
Level DNarrative ReviewEurope PMC
Mesenchymal stromal cells as potential immunomodulatory players in severe acute respiratory distress syndrome induced by SARS-CoV-2 infection
Narrative Review with a reported sample of 19 on Immune Modulation, published in World J Stem Cells (2020) — summary generated from the PubMed abstract.
2020
World J Stem Cells
22 citations
n = 19

In-depth reviewed studies (full Thai translation)

Evidence system

SVF Research Library

Nebulization of Mesenchymal Stem Cells Secretome Attenuates Acute Respiratory Distress Syndrome Caused by SARS-CoV-2 Corona Virus: An Open-Label, Controlled Trial

Therapeutic potential of mesenchymal stem cell-derived extracellular vesicles in SARS-CoV-2 and H1N1 influenza-induced acute lung injury.

Human mesenchymal stromal cells do not express ACE2 and TMPRSS2 and are not permissive to SARS-CoV-2 infection.

Mesenchymal stromal cells to fight SARS-CoV-2: Taking advantage of a pleiotropic therapy

Mesenchymal Stem Cell-Derived Exosomes Exhibit Promising Potential for Treating SARS-CoV-2-Infected Patients

SARS-CoV-2: the "Uncensored" Truth about Its Origin and Adipose-Derived Mesenchymal Stem Cells as New Potential Immune-Modulatory Weapon.

Mesenchymal stem cells in SARS-CoV-2 infection: A hype or hope

Adipose-derived mesenchymal stromal cells for the treatment of patients with severe SARS-CoV-2 pneumonia requiring mechanical ventilation. A proof of concept study.

Human Mesenchymal Stromal Cells Are Resistant to SARS-CoV-2 Infection under Steady-State, Inflammatory Conditions and in the Presence of SARS-CoV-2-Infected Cells.

Mesenchymal stromal cells as potential immunomodulatory players in severe acute respiratory distress syndrome induced by SARS-CoV-2 infection

In-depth reviewed studies (full Thai translation)

Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial

Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials

Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis